Vancomycin Insights: An Update on Mechanism, Activity, Toxicity, Resistance, and Novel Drug Delivery Systems
Iranian Journal of Pharmaceutical Research · 02.09.2025 · 24 (1)
DOI: 10.5812/ijpr-160885 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 02.09.2025. Verfasst von Maryam Tabarzad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Protein Technology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context: Vancomycin is an important antibiotic with a glycopeptide structure, effective against gram-positive bacterial infections through the inhibition of bacterial cell wall biosynthesis. It is indicated for the treatment of serious complicated skin, bloodstream, lower respiratory tract, bone, and joint infections. Primarily administered intravascularly, vancomycin shows negligible oral bioavailability. This review discusses the mechanism of action and toxicity of vancomycin, along with resistance issues and the mechanisms involved. Evidence Acquisition: We covered updated literature regarding various delivery systems for vancomycin, including nanoparticles, nanofibers, microparticles, liposomes, and hydrogels. Their antimicrobial evaluations and significant results are presented, alongside summaries of attempts for vancomycin oral delivery. The main issues of vancomycin, such as poor physicochemical properties (high molecular mass and aqueous solubility), poor oral bioavailability, minimum inhibitory concentration (MIC) creep, emergence of resistance, and high tendency to accumulate in the kidneys, can be addressed using novel drug delivery systems. Results and Conclusions: We summarized a range of novel drug delivery systems that have been investigated for enhancing the efficacy of vancomycin. The data collected here could be used as a guide for fabricating proper carriers for vancomycin delivery and selecting appropriate antimicrobial tests. Further in-depth studies on the mechanisms by which nanoparticles overcome resistance and enhance drug efficacy may pave the way for designing more effective systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Protein Technology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Dental Biomaterials, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Maryam Tabarzad, Maryam Torshabi, Mohadeseh Heidari, Azadeh Haeri, Seyedeh Maryam Mortazavi
Zitieren
APA
Tabarzad, M., Torshabi, M., Heidari, M., Haeri, A., & Mortazavi, S. M. (2025). Vancomycin Insights: An Update on Mechanism, Activity, Toxicity, Resistance, and Novel Drug Delivery Systems. Iranian Journal of Pharmaceutical Research, 24(1). https://doi.org/10.5812/ijpr-160885
Vancouver
Tabarzad M, Torshabi M, Heidari M, Haeri A, Mortazavi SM. Vancomycin Insights: An Update on Mechanism, Activity, Toxicity, Resistance, and Novel Drug Delivery Systems. Iranian Journal of Pharmaceutical Research. 2025;24(1). doi:10.5812/ijpr-160885
BibTeX
@article{Tabarzad2025,
author = {Tabarzad, Maryam and Torshabi, Maryam and Heidari, Mohadeseh and Haeri, Azadeh and Mortazavi, Seyedeh Maryam},
title = {Vancomycin Insights: An Update on Mechanism, Activity, Toxicity, Resistance, and Novel Drug Delivery Systems},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2025},
volume = {24},
number = {1},
doi = {10.5812/ijpr-160885}
}
EUVIMED